Shopping Cart
- Remove All
Your shopping cart is currently empty
5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $98 | In Stock | |
| 5 mg | $172 | In Stock | |
| 10 mg | $289 | In Stock | |
| 25 mg | $579 | In Stock | |
| 50 mg | $928 | In Stock | |
| 100 mg | $1,490 | In Stock | |
| 200 mg | $1,970 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $188 | In Stock |
| Description | 5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms. |
| Targets&IC50 | PFKFB4:8.6 μM (Ki) |
| In vitro | In H460 cells, 5MPN (0-30 μM; 24 hours) is able to inhibit the expression of PFKFB4[2]. |
| In vivo | 5MPN (120 mg/kg; p.o.) effectively inhibits the growth of Lewis lung carcinomas (LLC) in C57BL/6 mice and H460 human lung adenocarcinoma xenografts in athymic mice, without impacting body weight. A decline in Ki67-positive cells within LLC xenografts suggests 5MPN interferes with cell cycle progression in vivo[1]. |
| Synonyms | 5-MPN |
| Molecular Weight | 305.33 |
| Formula | C15H19N3O4 |
| Cas No. | 47208-82-2 |
| Smiles | COc1cccc2c(NCCCCCO[N+]([O-])=O)ccnc12 |
| Color | Yellow |
| Appearance | Viscous |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (262.01 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.